CellSig is led by Bart Vanhaesebroeck. We aim to improve understanding & drug targeting of the PI3K/PTEN pathway in cancer & beyond. #PI3Kδ#PI3Kactivators
Dear Klaus – thank you very much for your very kind message: you & your CellSig Colleagues made these PI3K discoveries possible, and continue to do so - we now only need more approved PI3K drugs, inhibitors or activators😊. Keep up the good work !
Congratulations to Sara Al-Jarrah Setó (‘Sarita’- in white T-shirt in front of picture) for successfully defending her PhD thesis in the @Cellsig Lab at @uclcancer, funded by PIPgen MSCA-ITN EU - pipgen.eu/ Wishing everyone a joyful and relaxing summer !!
Are you interested in the underlying molecular mechanisms of life? Explore the latest completed issue of the Biochemical Journal which delves into the newest developments in this exciting area! ow.ly/3JiA50Wi4Qc
🚀Check out this recent publication from the mTOR Pathway Diseases node - Challenges and opportunities from bench to bedside and the mTOR node tinyurl.com/mTORnode@BatemanLab@CharlotteRTye
Explore our themed collection, Cell Signaling in the 21st Century. This collection captures new developments in cell signaling through research, review articles and perspective pieces.
ow.ly/5ZB850UOJaa
ALT Biochemical Journal
Cell signaling in the 21st century
Biochemical Journal themed collection- read the latest published content
Inavo improves OS - great news for patients. This is the first PI3Ki to improve OS in ER MBC.
The future is triplets imo - eventually we will have firstline CDK4/6i PI3K/AKTi AI.
@PIK3CApathbreak@mbcallianceroche.com/media/releases/med…
Explore our themed collection, Cell Signaling in the 21st Century. This collection captures new developments in cell signaling through research, review articles and perspective pieces.
ow.ly/5ZB850UOJaa
ALT Biochemical Journal
Cell signaling in the 21st century
Biochemical Journal themed collection- read the latest published content
Interested in submitting your work to an independent society publisher? Our journals cover the breadth of the molecular biosciences. With open access options available, take a look at our journals and find the home for your work: ow.ly/HhES50UwuUg
ALT Submit your work
Portland Press welcomes the submission of research and review articles in all areas of the molecular biosciences.
portlandpress.com
Amazing meeting organised by Lemmon at the Royal Society- honoured to meet the pioneers in the EGF receptor field! This work has led to so many life-saving drugs - truly inspiring!
“Queremos estudiar en varios contextos patológicos los diferentes comportamientos que tienen las células endoteliales de un mismo vaso, lo que permitirá avanzar en el conocimiento de muchas enfermedades vinculadas a los vasos sanguíneos”.
La Dra. @MarionaGraupera explica en #BigVang de @LaVanguardia 🗞️ el proyecto #BEMOSAIC. No te pierdas la entrevista ⬇️
lavanguardia.com/ciencia/202…
@benefactgroup In December, they will be giving 120 charities £1,000 each over 12 days. It would mean so much for my charity @GoPI3Ks to win this so we can continue to help those living with PROS. To nominate please follow this link: movementforgood.com/index.ph…
thank you ☺️
With over 1.1M article views in 2023, Biochemical Journal has been at the forefront of exploring the mechanisms of life for over 100 years. Find out more about the journal on our website, and consider submitting your high-impact research
ow.ly/Gwx950U7UvX
ALT Biochemical Journal
Benefits of publishing with us
Open access- Publishing is available
Total article views in 2023, 1.1M
Independent- All our profits support the Biochemical Society
A meeting to mark 40 years since the EGF receptor was sequenced in Mike Waterfield’s lab at UCL. Promises to be a great meeting and it's free! royalsociety.org/science-eve…
Wonderful piece from Gareth and Alexander - I had the pleasure to meet Graham early in my career, an exciting era of major conceptual advances made by exceptional scientist like him, distilled from simple observations and minimal datasets.
Exciting opportunity to come and work with us @uclcancer@CRUKCOLcentre. We are looking for a Computational Scientist for #proteomics to characterise the regulatory phosphoproteome and apply data integration with other multiomics approaches. #TeamMassSpec
All Biochemical Journal papers undergo a rigorous peer review process; however, the Editorial Board is committed to ensuring that, if revisions are recommended, extra experiments not necessary to the paper will not be asked for.
ALT Biochemical Journal
The home of painless publishing
We have some free merchandise at the event, one is for the book lovers out there.📚Inauguration, The Denis Murphy Gallery, 26th September, 16.30, 1-3 Chesterton Rd, Cambridge CB4 3AD. Our other merchandise item will be in our next tweet 😃@PIPgen_ITN